About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 2NCT00652418

Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography

The objective of the study was to compare the efficacy of Magnevist (SH L 451 A) at doses of 0.1 mmol/kg and 0.2 mmol/kg in contrast-enhanced 3D-Magnetic Resonance Angiography in three regions (abdomi...

Lead sponsor: Bayer•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Bayer

Age

20 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients who are scheduled to undergo contrast-enhanced 3D-Magnetic Resonance Angiography

Exclusion Criteria

•Patients with an ankle brachial pressure index (ABPI) of 0.3 or less
•Patients with allergy to contrast media
•Patients with serious hepatic impairment
•Patients with serious renal impairment

Related studies

MRI Guided Management of Occlusive Peripheral Arterial Disease

NCT06782100 · Peripheral Vascular Diseases

Intervascular Post-Market Clinical Follow-Up (PMCF) Registry

NCT07322913 · Carotid Artery Diseases, Aortic Diseases, and more

RECRUITINGPhase 3

A Contrast Medium Sparing Strategy Using Automated CO2 Injection During PVI for Prevention of Major Adverse Kidney Events (MAKE)

NCT06656988 · Peripheral Vascular Diseases, Kidney Diseases

RECRUITINGPhase 4

Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone

NCT06777901 · Peripheral Arterial Diseases

Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 2

NCT04922762 · Peripheral Vascular Diseases

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 14, 2013Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment12

Start dateJul 2004

Last updatedOct 14, 2013

Condition

Magnetic Resonance Angiography Peripheral Vascular Diseases Peripheral Arterial Diseases

Locations shown

Hirosaki-shi, Aomori

Funai-gun, Kyoto

Hamamatsu, Shizuoka

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 14, 2013Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions